*As of Q1 2020

Since 2004 Tigermed has undertaken vaccine clinical trials including new vaccines registration and phase I/II/III and IV with the provincial CDC. Tigermed has a long-term good relations of cooperation with CDC to undertake clinical projects including, covering service of the vaccine clinical design, inspection, audit, statistics and detection. Tigermed has long-term strategic partners of outstanding enterprises abroad and in China.

• Clinical research experience in phase I/II/III vaccine registration and post-marketing clinical research;
• More than 15 cases of large-scale vaccine clinical projects;
• International partners including Merck, Sanofi Pasteur, etc.